Healthcare >> CEO Interviews >> July 11, 2006

Philip Young – Insmed Inc (insm)

TWST: What is Insmed?

Mr. Young: Insmed is a biotechnology company that's focused on

modulating and regulating the IGF-1 (Insulin-like Growth Factor-1)

pathway. We have development programs